Prehospital triple antiplatelet therapy in patients with acute ST elevation myocardial infarction leads to better platelet aggregation inhibition and clinical outcome than dual antiplatelet therapy. (Q42871120)
Jump to navigation
Jump to search
scientific article published on 3 October 2010
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Prehospital triple antiplatelet therapy in patients with acute ST elevation myocardial infarction leads to better platelet aggregation inhibition and clinical outcome than dual antiplatelet therapy. |
scientific article published on 3 October 2010 |
Statements
Prehospital triple antiplatelet therapy in patients with acute ST elevation myocardial infarction leads to better platelet aggregation inhibition and clinical outcome than dual antiplatelet therapy (English)
Jan Paul Ottervanger
Jaap Jan J Smit
Jochem W van Werkum
Jurrien ten Berg
Robbert Slingerland
Ton Heestermans
Thorsten Dill
Arnoud W J van 't Hof
Ongoing Tirofiban in Myocardial Infarction Evaluation (On-TIME) trial investigators
3 October 2010